genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Cellectis
Insights
Enzymatic DNA Synthesis: Shorter Waits, Longer Strands
Drug Discovery
Gene Therapy Briefs: Activist Investor Reported to Take $1B Stake in BioMarin
Bioprocessing
Cell Therapy Cure for Vaccine Sector Production Ills
Cancer
Cellectis Starts BPDCN Phase I Trial with Gene-Edited CAR-T Therapy
News
Cellectis Granted T Cell CRISPR Patent in Europe
News
Cellectis Wins Second NIH iPSC Contract
Bioprocessing
Medicago Taps Cellectis to Boost Therapeutic Protein Production in Tobacco Plants
News
Cellectis Nabs TAL Effector IP from Minnesota and Iowa State Universities
News
Cellectis to Leverage Evrogen’s Fluorescent Proteins
News
Cellectis and the Center for iPS Cells Research and Application Join Forces
1
2
3
Page 1 of 3
Scroll Up
Scroll Up
